Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

CV Sciences, Inc. (CVSI)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0459+0.0027 (+6.19%)
At close: 03:49PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0432
Open0.0440
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0425 - 0.0460
52 Week Range0.0300 - 0.0600
Volume260,514
Avg. Volume260,085
Market Cap7.093M
Beta (5Y Monthly)0.74
PE Ratio (TTM)4.59
EPS (TTM)0.0100
Earnings DateNov 13, 2023 - Nov 17, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CVSI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CV SCIENCES INC
    Analyst Report: Gap, Inc.Gap Inc. is a specialty retailer of clothing, accessories and personal care products for adults, teens and children. The San Francisco-based company has four brands: Gap, Banana Republic, Athleta, and Old Navy. GAP operates approximately 2,600 stores and over 850 franchise locations in more than 40 countries. The company has about 97,000 employees.
    Rating
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
  • PR Newswire

    CV Sciences, Inc. Launches Reserve Sleep Gummies

    CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced the launch of +PlusCBD™Reserve Collection Sleep Gummies as the brand continues to expand into the sleep aid market.

  • Insider Monkey

    CV Sciences, Inc. (PNK:CVSI) Q2 2023 Earnings Call Transcript

    CV Sciences, Inc. (PNK:CVSI) Q2 2023 Earnings Call Transcript August 14, 2023 Operator: Hello, and welcome to the CV Sciences, Inc. Second Quarter 2023 Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It’s now my pleasure to turn the call over to your host, Brendan Hawkins. Please go ahead. Brendan Hawkins: […]

  • PR Newswire

    CV Sciences, Inc. Reports Second Quarter 2023 Financial Results

    CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2023.

Advertisement
Advertisement